US Doctor Beats Ebola After Treatment in Germany

After more than two weeks fighting a rare strain of Ebola, American surgeon Peter Stafford walked out of a Berlin hospital healthy and free from quarantine.

The 39-year-old doctor contracted the Bundibugyo virus while operating on an Ebola patient in the Democratic Republic of Congo. He was working with a Christian missionary group when he became infected, even before the outbreak was officially declared on May 15.

Stafford was flown to Berlin's Charite hospital on May 20 in a specialized aircraft under strict safety protocols. His medical team treated him with experimental therapies currently in trials for this specific virus strain.

"Words cannot adequately express my gratitude," Stafford said in a hospital statement. But he quickly turned attention back to those still suffering, adding that "our thoughts remain with the people in the Congo who do not have access to such care."

His wife and four children also arrived in Berlin and were placed in quarantine as high-risk contacts. The entire family was cleared to leave isolation on Saturday, all showing no symptoms.

The Bright Side

Dr. Leif Erik Sander, director of the hospital's infectious diseases department, called Stafford's recovery "a significant therapeutic success." While no approved vaccine exists yet for the Bundibugyo strain, three candidates are being fast-tracked for trials.

The experimental treatments that saved Stafford's life are now proving their potential. This success gives researchers valuable data as they race to develop effective therapies for future patients.

Stafford's recovery shows that even the rarest, most dangerous diseases can be beaten with advanced medical care and innovative treatments. His case provides hope that these experimental therapies could eventually reach the communities that need them most.

The outbreak continues to spread, with 488 cases now confirmed in the DRC and 19 in Uganda. But each medical victory like Stafford's brings scientists one step closer to ending Ebola's threat for good.